BSA
NGVT icon

Braun Stacey Associates’s Ingevity NGVT Stock Holding History

Braun Stacey Associates’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-173,878
Closed -$15.2M – 126
2019
Q4 		$15.2M Buy
173,878
+8,381
+5% +$733K 0.85% 64
2019
Q3 		$14M Buy
165,497
+16,015
+11% +$1.43M 0.89% 59
2019
Q2 		$15.7M Buy
149,482
+14,085
+10% +$1.42M 1.01% 41
2019
Q1 		$14.3M Buy
135,397
+19,542
+17% +$1.96M 0.95% 51
2018
Q4 		$9.7M Buy
+115,855
New +$10.5M 0.77% 65

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BBCM
Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Braun Stacey Associates's NGVT Position: Q1 2020 in Review

Braun Stacey Associates sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 173,878 shares — an estimated $15.2M sold.

Braun Stacey Associates first reported a position in NGVT in Q4 2018 and held it in 5 quarters. The position peaked at $15.7M in Q2 2019. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • Braun Stacey Associates reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • Braun Stacey Associates sold 173,878 Ingevity shares in Q1 2020, an estimated $15.2M.
  • Braun Stacey Associates first reported a position in Ingevity in Q4 2018 and held it in 5 quarters.
  • Braun Stacey Associates's Ingevity position peaked at $15.7M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Braun Stacey Associates's 13F filing for Q1 2020, filed 9 Jun 2020.